Boothbay Fund Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-86,700
Closed -$4.74M 2081
2025
Q3
$4.74M Buy
+86,700
New +$4.33M 0.07% 324
2024
Q2
Sell
-65,000
Closed -$4.49M 1629
2024
Q1
$4.49M Buy
+65,000
New +$4.11M 0.09% 254

Other funds holding EXAS

Boothbay Fund Management's EXAS Position: Q1 2026 in Review

Boothbay Fund Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 66,782 shares — an estimated $6.78M sold.

Boothbay Fund Management first reported a position in EXAS in Q4 2020 and held it in 3 quarters. The position peaked at $22.8M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Boothbay Fund Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 66,782 Exact Sciences shares in Q1 2026, an estimated $6.78M.
  • Boothbay Fund Management first reported a position in Exact Sciences in Q4 2020 and held it in 3 quarters.
  • Boothbay Fund Management's Exact Sciences position peaked at $22.8M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.